These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8801573)
1. Involvement of catecholamine receptor activities in modulating the incidence of yawning in rats. Kimura H; Yamada K; Nagashima M; Furukawa T Pharmacol Biochem Behav; 1996 Apr; 53(4):1017-21. PubMed ID: 8801573 [TBL] [Abstract][Full Text] [Related]
2. Role of adrenergic neuronal activity in the yawning induced by tacrine and NIK-247 in rats. Kimura H; Yamada K; Nagashima M; Matsumoto S; Ishii Y; Yoshida S; Fujii K; Furukawa T Pharmacol Biochem Behav; 1992 Dec; 43(4):985-91. PubMed ID: 1361995 [TBL] [Abstract][Full Text] [Related]
3. Involvement of central beta-adrenoceptors in the regulation of yawning responses. Yamada K; Matsumoto S; Nagashima M; Kumagai M; Kimura H; Furukawa T Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):26-30. PubMed ID: 2571945 [TBL] [Abstract][Full Text] [Related]
4. Involvement of beta-adrenoceptors in regulation of the yawning induced by neuropeptides, oxytocin and alpha-melanocyte-stimulating hormone, in rats. Fujikawa M; Yamada K; Nagashima M; Furukawa T Pharmacol Biochem Behav; 1995 Mar; 50(3):339-43. PubMed ID: 7617671 [TBL] [Abstract][Full Text] [Related]
6. The new muscarinic M1-receptor agonist YM796 evokes yawning and increases oxytocin secretion from the posterior pituitary gland in rats. Fujikawa M; Yamada K; Nagashima M; Domae M; Furukawa T Pharmacol Biochem Behav; 1996 Sep; 55(1):55-60. PubMed ID: 8870038 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat. Yamada K; Matsumoto S; Nagashima M; Shirakawa K; Furukawa T J Neural Transm Gen Sect; 1990; 79(1-2):19-24. PubMed ID: 1967531 [TBL] [Abstract][Full Text] [Related]
8. Influence of different adrenoceptor agonists and antagonists on physostigmine-induced yawning in rats. Zarrindast MR; Fazli-Tabai S; Semnanian S; Fathollahi Y Pharmacol Biochem Behav; 1999 Jan; 62(1):1-5. PubMed ID: 9972838 [TBL] [Abstract][Full Text] [Related]
9. Treatment with dexamethasone alters yawning behavior induced by cholinergic but not dopaminergic agonist. Hipólide DC; Lobo LL; De Medeiros R; Neumann B; Tufik S Physiol Behav; 1999 Jan 1-15; 65(4-5):829-32. PubMed ID: 10073488 [TBL] [Abstract][Full Text] [Related]
10. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist. Ferrari F; Pelloni F; Giuliani D Psychopharmacology (Berl); 1993; 113(2):172-6. PubMed ID: 7855178 [TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat. Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158 [TBL] [Abstract][Full Text] [Related]
12. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Docherty JR Eur J Pharmacol; 2012 Mar; 679(1-3):90-4. PubMed ID: 22290390 [TBL] [Abstract][Full Text] [Related]
13. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067 [TBL] [Abstract][Full Text] [Related]
14. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study. Tang AH; Himes CS Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616 [TBL] [Abstract][Full Text] [Related]
15. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist. Smith HP; Nichols DE; Mailman RB; Lawler CP Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats. Matsumoto S; Yamada K; Nagashima M; Domae M; Shirakawa K; Furukawa T Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):21-5. PubMed ID: 2571944 [TBL] [Abstract][Full Text] [Related]
17. The modulatory role of M2 muscarinic receptor on apomorphine-induced yawning and genital grooming. Gamberini MT; Bolognesi ML; Nasello AG Neurosci Lett; 2012 Dec; 531(2):91-5. PubMed ID: 23041487 [TBL] [Abstract][Full Text] [Related]
18. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning. Ushijima I; Mizuki Y; Yamada M Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698 [TBL] [Abstract][Full Text] [Related]
19. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Li SM; Collins GT; Paul NM; Grundt P; Newman AH; Xu M; Grandy DK; Woods JH; Katz JL Behav Pharmacol; 2010 May; 21(3):171-81. PubMed ID: 20463460 [TBL] [Abstract][Full Text] [Related]
20. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Haapalinna A; Leino T; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]